NewEdge Wealth LLC Takes Position in Danaher Corporation $DHR

Posted by George Bondi on Aug 20th, 2026

NewEdge Wealth LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, Holdings Channel reports. The institutional investor acquired 23,171 shares of the conglomerate’s stock, valued at approximately $4,414,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. grew its holdings in Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares during the period. Legal & General Group Plc raised its position in shares of Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares in the last quarter. Advisors Capital Management LLC lifted its stake in shares of Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after purchasing an additional 6,720 shares during the period. Handelsbanken Fonder AB lifted its stake in shares of Danaher by 10.9% in the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after purchasing an additional 28,425 shares during the period. Finally, Swiss Life Asset Management Ltd boosted its position in shares of Danaher by 12.1% during the 4th quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock valued at $26,402,000 after purchasing an additional 12,416 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR opened at $211.92 on Thursday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $148.98 billion, a PE ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78. The stock has a 50-day moving average of $194.30 and a 200-day moving average of $192.44. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley dropped their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen cut their price target on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Finally, UBS Group lowered their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Read Our Latest Analysis on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

NewEdge Wealth LLC Takes Position in Danaher Corporation $DHR

Danaher Stock Performance

Analyst Upgrades and Downgrades

Danaher Company Profile

See Also

You might be interested in: